Recent News

• 11.14.2025 - BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update
• 08.14.2025 - BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update
• 08.08.2025 - BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update
• 07.17.2025 - BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB
• 07.08.2025 - FDA Review of Citizen Petition Offers a Fresh Look at NurOwn®'s Evidence of Treatment Effectiveness
• 06.16.2025 - BrainStorm Announces New Survival Data from Expanded Access Program Cohort: Remarkably 90% of ALS Patients Survived Over 5 Years with NurOwn®

Recent Filings

• 11.14.2025 - 8-K Current report
• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.14.2025 - EX-99.1 EX-99.1
• 11.06.2025 - 8-K Current report
• 10.09.2025 - 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
• 08.14.2025 - EX-99.1 EX-99.1
• 08.14.2025 - 8-K Current report
• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.22.2025 - RW Registration Withdrawal Request
• 07.17.2025 - 8-K Current report